News

CMC ICOS Biologics and Harpoon Therapeutics announced that they have entered into an agreement for the development and manufacturing of HPN424, HPN536, and HPN217, representing three…
Read More...

Aprecia Pharmaceuticals and Cycle Pharmaceuticals announced they have signed a partnership agreement to develop and commercialize  orphan drugs using three-dimensionally printed…
Read More...

Medicure announced that, through its subsidiary, Medicure International Inc., it has acquired, from a large multinational pharmaceutical company, an exclusive license to sell and market…
Read More...

BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to…
Read More...

Pfizer Inc. announced that the United States Food and Drug Administration (FDA) has approved XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR (tofacitinib) extended release 11 mg once…
Read More...

Zytoprotec announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to PD-protec, the Company's peritoneal dialysis fluid for the…
Read More...

SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, is now offering clients large molecule bioanalytical services at its laboratory in Wavre,…
Read More...

Abzena plc has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate…
Read More...

MeiraGTx announced that the Offices of Orphan Products Development and Pediatric Therapeutics of the U.S. Food and Drug Administration (FDA) have granted rare pediatric disease…
Read More...

Carmot Therapeutics, announced that it has entered into a multi-year drug discovery collaboration and licensing agreement with Amgen (Thousand Oaks, CA). As part of the agreement,…
Read More...

Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Lyomark Pharma, an established provider of high-quality medicines for the hospital…
Read More...

Gilead Sciences, Inc. and its cell therapy subsidiary Kite announced that they have entered into a definitive agreement under which they have agreed to acquire Cell Design Labs, Inc.,…
Read More...

An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly…
Read More...

Acorda Therapeutics announced the resubmission of its New Drug Application (NDA) for INBRIJA to the U.S. Food and Drug Administration (FDA). INBRIJA is an investigational treatment for…
Read More...

Neon Therapeutics announced that it has entered a clinical trial collaboration with Merck (known as MSD outside the United States and Canada) to evaluate Neon Therapeutics’ proprietary…
Read More...

Concentric Analgesics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to CA-008 for the treatment of post-surgical pain. CA-008 is a…
Read More...

Carmot Therapeutics, announced that it has entered into a multi-year drug discovery collaboration and licensing agreement with Amgen (Thousand Oaks, CA). As part of the agreement,…
Read More...

Advanced Clinical, a clinical development organization providing CRO, FSP, Quality & Validation, and Strategic Resourcing services, announced the opening of its new offices in…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Avastin (bevacizumab) for the treatment of adults with…
Read More...

Pfizer and Basilea Pharmaceutica announced that they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization rights in China and…
Read More...